当前位置:首页 - 行情中心 - 百诚医药(301096) - 财务分析

百诚医药

(301096)

  

流通市值:47.60亿  总市值:75.00亿
流通股本:6912.19万   总股本:1.09亿

百诚医药(301096)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.50亿元,每股收益0.46元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益274138.85万元,未分配利润49403.35万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产383469.09万元,负债109330.24万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入215,702,841.541,017,448,123.5713,806,299.44423,862,084.23
营业总成本164,553,615.62714,528,892.94479,524,433.1287,266,507.76
营业利润47,805,281.44297,021,668.91225,718,817.13129,157,143.22
利润总额47,897,315.79295,679,490.19224,356,233.75127,710,560.08
净利润49,818,209.14272,014,711.17201,528,646.46119,501,817.13
其他综合收益-1,349.85-136,186.95-63,253.26-61,142.5
综合收益总额49,816,859.29271,878,524.22201,465,393.2119,440,674.63
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,669,571,960.021,607,783,925.031,558,714,511.131,670,696,433.93
非流动资产合计2,165,118,984.832,061,322,212.081,847,384,832.961,710,826,627.46
资产总计3,834,690,944.853,669,106,137.113,406,099,344.093,381,523,061.39
流动负债合计963,418,124.66846,190,707.95682,556,522.61629,826,519.52
非流动负债合计129,884,297.52138,778,298.04123,265,154.91207,003,987.11
负债合计1,093,302,422.18984,969,005.99805,821,677.52836,830,506.63
归属于母公司股东权益合计2,741,388,522.672,684,137,131.122,600,277,666.572,544,692,554.76
股东权益合计2,741,388,522.672,684,137,131.122,600,277,666.572,544,692,554.76
负债和股东权益合计3,834,690,944.853,669,106,137.113,406,099,344.093,381,523,061.39
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计110,905,629.87809,002,058.59559,175,466.96351,422,673.96
经营活动现金流出小计232,881,238.59718,548,644.85525,639,822.42351,245,806.74
经营活动产生的现金流量净额-121,975,608.7290,453,413.7433,535,644.54176,867.22
投资活动现金流入小计97,926,542.6139,713,617.3382,294,99484,201,112.33
投资活动现金流出小计330,999,420.68907,129,411.68659,508,370.87466,908,189.92
投资活动产生的现金流量净额-233,072,878.08-767,415,794.35-577,213,376.87-382,707,077.59
筹资活动现金流入小计514,000,000490,975,623.28290,000,000280,000,000
筹资活动现金流出小计252,752,520.36246,493,909.29127,637,565.6891,650,898.37
筹资活动产生的现金流量净额261,247,479.64244,481,713.99162,362,434.32188,349,101.63
汇率变动对现金及现金等价物的影响-1,389.26-134,499.97-63,263.13-61,142.5
现金及现金等价物净增加额-93,802,396.42-432,615,166.59-381,378,561.14-194,242,251.24
期末现金及现金等价物余额684,650,318.52778,452,714.94829,689,320.391,016,825,630.29
最新报告期:2024-04-29
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华安证券谭国超3.284.415.682024-04-29
国元证券马云涛3.274.475.982024-04-27
西部证券李梦园3.244.225.642024-04-25
华鑫证券胡博新3.324.395.682024-04-25
东海证券伍可心,杜永宏3.454.666.162024-04-24
TOP↑